| Date |
Press Announcement |
| 12/10/2019 |
FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations |
| 11/25/2019 |
FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns |
| 10/22/2019 |
FDA, FTC warn company marketing unapproved cannabidiol products with unsubstantiated claims to treat teething and ear pain in infants, autism, ADHD, Parkinson’s and Alzheimer’s disease |
| 09/30/2019 |
FDA and DEA warn website operators illegally selling opioids |
| 09/03/2019 |
Federal judge enters consent decree against Tennessee drug, dietary supplement and device distributors, Basic Reset and Biogenyx, for drug, device and dietary supplement violations |
| 07/23/2019 |
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety |
| 06/25/2019 |
FDA issues warnings to companies selling illegal, unapproved kratom drug products marketed for opioid cessation, pain treatment and other medical uses |
| 06/14/2019 |
Federal officials seize adulterated dietary supplements from Life Rising Corporation due to poor manufacturing practices |
| 05/30/2019 |
FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions |
| 03/19/2019 |
FDA takes action against marketer of unapproved products claiming to treat addiction, chronic pain and other serious conditions |
| 02/11/2019 |
FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease |
